193 related articles for article (PubMed ID: 29891845)
1. A novel role of C-terminus in introducing a functionally flexible structure critical for the biological activity of botulinum neurotoxin.
Feltrup TM; Patel K; Kumar R; Cai S; Singh BR
Sci Rep; 2018 Jun; 8(1):8884. PubMed ID: 29891845
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of activation of endopeptidase activity of botulinum neurotoxin type E.
Kukreja RV; Sharma SK; Singh BR
Biochemistry; 2010 Mar; 49(11):2510-9. PubMed ID: 20178376
[TBL] [Abstract][Full Text] [Related]
3. Comparative role of neurotoxin-associated proteins in the structural stability and endopeptidase activity of botulinum neurotoxin complex types A and E.
Kukreja RV; Singh BR
Biochemistry; 2007 Dec; 46(49):14316-24. PubMed ID: 18004882
[TBL] [Abstract][Full Text] [Related]
4. Role of two active site Glu residues in the molecular action of botulinum neurotoxin endopeptidase.
Kukreja RV; Sharma S; Cai S; Singh BR
Biochim Biophys Acta; 2007 Feb; 1774(2):213-22. PubMed ID: 17189717
[TBL] [Abstract][Full Text] [Related]
5. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
[TBL] [Abstract][Full Text] [Related]
6. Biologically active novel conformational state of botulinum, the most poisonous poison.
Kukreja R; Singh B
J Biol Chem; 2005 Nov; 280(47):39346-52. PubMed ID: 16179354
[TBL] [Abstract][Full Text] [Related]
7. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
Ambrin G; Kumar R; Singh BR
Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
9. Endopeptidase activities of botulinum neurotoxin type B complex, holotoxin, and light chain.
Wang HH; Riding S; Lindo P; Singh BR
Appl Environ Microbiol; 2010 Oct; 76(19):6658-63. PubMed ID: 20693440
[TBL] [Abstract][Full Text] [Related]
10. Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting.
Singh BR
Neurotox Res; 2006 Apr; 9(2-3):73-92. PubMed ID: 16785103
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin.
Edupuganti OP; Ovsepian SV; Wang J; Zurawski TH; Schmidt JJ; Smith L; Lawrence GW; Dolly JO
FEBS J; 2012 Jul; 279(14):2555-67. PubMed ID: 22607388
[TBL] [Abstract][Full Text] [Related]
12. Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.
Kumaran D; Adler M; Levit M; Krebs M; Sweeney R; Swaminathan S
Bioorg Med Chem; 2015 Nov; 23(22):7264-73. PubMed ID: 26522088
[TBL] [Abstract][Full Text] [Related]
13. The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site.
Mizanur RM; Frasca V; Swaminathan S; Bavari S; Webb R; Smith LA; Ahmed SA
J Biol Chem; 2013 Aug; 288(33):24223-33. PubMed ID: 23779108
[TBL] [Abstract][Full Text] [Related]
14. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity.
Segelke B; Knapp M; Kadkhodayan S; Balhorn R; Rupp B
Proc Natl Acad Sci U S A; 2004 May; 101(18):6888-93. PubMed ID: 15107500
[TBL] [Abstract][Full Text] [Related]
16. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
17. Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa.
Williamson LC; Halpern JL; Montecucco C; Brown JE; Neale EA
J Biol Chem; 1996 Mar; 271(13):7694-9. PubMed ID: 8631808
[TBL] [Abstract][Full Text] [Related]
18. Substrates and controls for the quantitative detection of active botulinum neurotoxin in protease-containing samples.
Bagramyan K; Kaplan BE; Cheng LW; Strotmeier J; Rummel A; Kalkum M
Anal Chem; 2013 Jun; 85(11):5569-76. PubMed ID: 23656526
[TBL] [Abstract][Full Text] [Related]
19. Mastoparan-7 rescues botulinum toxin-A poisoned neurons in a mouse spinal cord cell culture model.
Zhang P; Ray R; Singh BR; Ray P
Toxicon; 2013 Dec; 76():37-43. PubMed ID: 24047963
[TBL] [Abstract][Full Text] [Related]
20. Expression and purification of the light chain of botulinum neurotoxin A: a single mutation abolishes its cleavage of SNAP-25 and neurotoxicity after reconstitution with the heavy chain.
Zhou L; de Paiva A; Liu D; Aoki R; Dolly JO
Biochemistry; 1995 Nov; 34(46):15175-81. PubMed ID: 7578132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
